MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from debt
$38,785K
Proceeds from issuance of
common stock under the...
$201K
Proceeds from exercise of
common stock options
$40K
Net cash provided by
financing activities
$2,026K
Canceled cashflow
$37,000K
Net (decrease)
increase in cash, cash...
-$8,180K
Canceled cashflow
$2,026K
Stock-based compensation
expense
$4,136K
Accounts receivable
-$1,204K
Non-cash lease expense
$415K
Depreciation and
amortization expense
$220K
Inventory write-down
(recovery), net
$144K
Loss on
extinguishment of debt
-$107K
Pik interest
incurred but not paid on...
$67K
Other assets
-$61K
Income taxes payable
$51K
Amortization of debt discount
and debt issuance...
$46K
Deferred revenue
$14K
Deferred tax liability
-$4K
Repayment of debt
$37,000K
Net cash used in
operating activities
-$10,097K
Canceled cashflow
$6,469K
Effect of exchange rate
changes on cash and cash...
-$100K
Net cash (used in)
provided by investing...
-$9K
Net loss
-$13,654K
Accrued liabilities
-$1,165K
Inventory
$959K
Accounts payable
-$430K
Lease liabilities
-$329K
Prepaid expenses and
other current assets
$29K
Purchases of property and
equipment and internal...
$9K
Back
Back
Cash Flow
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)
source: myfinsight.com